Uploaded October 2025 | Updated September 2026, 2 weeks ago
The Variant to Function (V2F) Symposium is a one-day scientific conference held at the Broad Institute’s Merkin Lobby and Auditorium. Hosted by the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, this symposium dives into the critical challenge of translating genetic associations into actionable therapeutic targets, including biomarkers and assays for patient stratification.
Keynote: "Placing billion-dollar bets: human genetics in drug R&D”.
Robert Plenge, MD, PhD, Executive Vice President and Chief Research Officer at Bristol Myers Squibb
Co-chaired by Melina Claussnitzer and Kasper Lage, this event showcases a day of high-impact science and cross-disciplinary discussions aimed at accelerating genetically-informed approaches in healthcare
For more information, visit: broadinstitute.org
Copyright Broad Institute, 2025. All rights reserved.
The Variant to Function (V2F) Symposium is a one-day scientific conference held at the Broad Institute’s Merkin Lobby and Auditorium. Hosted by the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, this symposium dives into the critical challenge of translating genetic associations into actionable therapeutic targets, including biomarkers and assays for patient stratification.
Keynote: "Placing billion-dollar bets: human genetics in drug R&D”.
Robert Plenge, MD, PhD, Executive Vice President and Chief Research Officer at Bristol Myers Squibb
Co-chaired by Melina Claussnitzer and Kasper Lage, this event showcases a day of high-impact science and cross-disciplinary discussions aimed at accelerating genetically-informed approaches in healthcare
For more information, visit: broadinstitute.org
Copyright Broad Institute, 2025. All rights reserved.
